author-photo

Joao Lima

Institute of Cancer Research

3

Papers

9

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
AZD5363, a catalytic pan-Akt inhibitor, in Akt1 E17K mutation positive advanced solid tumors

2015
Show All
- Source
- Cite
- Save
Citations (4)
339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH)

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)